Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
300 participants
OBSERVATIONAL
2022-08-01
2024-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To address the aforementioned gap, we propose to conduct a survey study to determine the prevalence of purpose disruption in two clinical populations and determine if the prevalence of purpose disruption in these populations is different from that of a normative population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Purpose Project: Reclaiming Life Purpose After Breast Cancer (Feasibility Study)
NCT03233334
Feasibility of Providing a Purpose Renewal Intervention for Cancer Survivors Via Virtual Groups
NCT04767464
Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
NCT00309933
A Survey of Sleep Problems in Survivors of Breast Cancer
NCT00587340
Assessing the Time Demands of Cancer
NCT05708703
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adults with Early Stage Cancer
Survey
Completion of a Purpose in Life Survey
Adults with Traumatic Brain Injury
Survey
Completion of a Purpose in Life Survey
Health Control Adults
Survey
Completion of a Purpose in Life Survey
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey
Completion of a Purpose in Life Survey
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stage 1, 2, 3 cancer
* Cancer types: breast cancer, non-Hodgkin's lymphoma; colorectal cancer
* Receiving oncology services or treatment through AHCI
* Have completed primary cancer treatment within the past 12 months
* Able to communicate in English;
* Able to see and read (with or without assistive devices);
* Has access to a device (computer, phone, tablet) and an email address;
* Access to an internet connection.
* Has a known email address (in EPIC) and/or home telephone number
* Adults who sustained a traumatic brain injury within the past 12 months.
* Attending the 2022 MN State Fair
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mary Radomski
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mary Radomski
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary V Radomski, PhD
Role: PRINCIPAL_INVESTIGATOR
Allina Health - Courage Kenny Rehabilitation Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1920306
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.